INGN earnings analysis
What we found in INGN's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Q2 2026 revenue was $95.084 million, increasing approximately 11.9% sequentially and 3.4% year over year, while EPS improved to $0.00 from losses of $0.30 in Q1 2026 and $0.15 in Q2 2025. The supplied filing text does not provide gross margin, operating margin, cash flow, balance-sheet, segment, or quantitative outlook data, limiting the assessment of underlying operating performance. Share repurchases continued, with 847,050 shares bought at an average price of $6.64 and $22.5 million remaining under the authorization. Risk factors were unchanged from prior filings.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue grew sequentially and year over year
- Q2 revenue was $95.084 million, up from $85 million in Q1 2026, an increase of approximately 11.9%, and up from $92 million in Q2 2025, an increase of approximately 3.4%.
- EPS improved to break-even
- Reported EPS was $0.00 versus negative $0.30 in Q1 2026 and negative $0.15 in Q2 2025, indicating a sequential and year-over-year improvement in per-share earnings.
- Share repurchases continued
- The company repurchased 847,050 shares during Q2 at an average price of $6.64 per share, under the $30.0 million February 2026 authorization.
- Repurchase authorization remains available
- At June 30, 2026, $22.5 million remained available under the share-repurchase program, which expires December 31, 2027, unless fully utilized earlier.
- Controls remained effective
- Management concluded that disclosure controls and procedures were effective at the reasonable-assurance level as of June 30, 2026, and reported no material change in internal control over financial reporting during the quarter.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Ongoing share-repurchase liquidity use
- The company repurchased 847,050 shares for approximately $5.6 million during Q2, based on 847,050 shares at an average price of $6.64. The program had $22.5 million remaining under its $30.0 million authorization, representing a potential future use of liquidity.
- Litigation costs and management diversion
- The filing states that litigation and investigations arising in the normal course could create defense and settlement costs and divert management resources, although the company does not anticipate a material adverse effect from these proceedings.
- No material risk-factor changes disclosed
- No material changes to previously disclosed risk factors were identified relative to the 2025 Form 10-K filed February 27, 2026, or the Q1 2026 Form 10-Q filed May 8, 2026. Accordingly, the filing provides no new quantified risk-factor update.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.0
What they said about what is next.
The supplied 10-Q text does not include quantitative revenue or EPS guidance. The prior 8-K cited full-year revenue guidance of $366 million to $373 million, but this filing does not explicitly reaffirm or change it.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 8, 2026
- Inogen reported Q1 2026 results with revenue of $85.1 million, surpassing expectations by 3.4%, but net loss widened to $8.3 million. The company faced a significant decline in U.S. rental revenue, although…
- 10-Q · August 8, 2025
- Inogen reported Q2 revenue of $92,277,000 (up $3,512,000 vs Q2 2024 and up ~$10.0M vs Q1 2025) with gross margin of 44.8% and an improved operating margin of -6.6%. GAAP diluted net loss per share narrowed to $(0.15)…
- 10-Q · November 8, 2024
- Inogen reported Q3 revenue of $88,834,000 (up from $83,967,000 a year ago) and a narrower GAAP loss per share of $0.25 (basic and diluted) for the quarter. Gross margin expanded to 46.5% from roughly 40.2% a year ago…
- 10-K · March 1, 2024
- Inogen 10-K emphasizes a growth strategy built on direct-to-consumer sales and rental penetration in the U.S., continued product innovation (Rove 6, Inogen Connect) and geographic/product expansion via the Sept 14, 2023…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing INGN makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever